SCHEMBL20014231

SCHEMBL20014231

COC(=O)Cc1cnc(NC(=O)Cc2cccnc2)s1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNE1 P24864 11/20 0.58
▸ CDK2 P24941 11/20 0.58
▸ CDK5 Q00535 8/20 0.58
▸ CDK1 P06493 3/20 0.54
▸ CDK4 P11802 3/20 0.54
▸ CCNB1 P14635 3/20 0.54
▸ CCND1 P24385 3/20 0.54
▸ CCNE2 O96020 3/20 0.54
▸ CCNB2 O95067 2/20 0.54
▸ CCNB3 Q8WWL7 2/20 0.54
▸ CCND2 P30279 1/20 0.54
▸ CCND3 P30281 1/20 0.54
▸ GLS O94925 6/20 0.54
▸ ALDH1A1 P00352 3/20 0.48
▸ CCNT1 O60563 1/20 0.48
▸ CCNA2 P20248 1/20 0.48
▸ CDK7 P50613 1/20 0.48
▸ CDK9 P50750 1/20 0.48
▸ CCNH P51946 1/20 0.48
▸ MNAT1 P51948 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20014229 0.87 CCNE1 (0.62) CCNE1CDK2CDK5CDK1CDK4
SCHEMBL5835963 0.84 CCNE1 (0.58) CCNE1CDK2CDK5CDK1CDK4
SCHEMBL5836526 0.83 CCNE1 (0.64) CCNE1CDK2CDK5CDK1CDK4
SCHEMBL20014219 0.81 CCNE1 (0.52) CCNE1CDK2CDK5CDK1CDK4
SCHEMBL13694242 0.79 GLS (0.59) CCNE1CDK2CDK5CDK1CDK4
SCHEMBL27578137 0.79 CCNE1 (0.76) CCNE1CDK2CDK5CDK1CDK4
SCHEMBL27549850 0.79 CCNE1 (0.77) CCNE1CDK2CDK5CDK1CDK4
SCHEMBL29645003 0.79 CCNE1 (0.77) CCNE1CDK2CDK5CDK1CDK4
SCHEMBL29466814 0.78 NAPRT (0.62) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9
SCHEMBL178130 0.78 NAPRT (0.62) ALDH1A1SMN1; SMN2CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4275759-A2 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER Dana-Farber Cancer Institute, Inc. (US) 2023-11-15 — — EP disclosed
EP-3515449-B1 QUINOLINE DERIVATIVES AS CHROMOBOX (CBX) PROTEIN INHIBITORS FOR TREATING CANCER DANA FARBER CANCER INST INC (US) 2023-07-12 — — EP disclosed
WO-2018058029-A1 CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2018-03-29 — — WO disclosed
Send feedback